Fig. 3From: Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinomaStratification analysis of the ten-microRNA signature. Kaplan–Meier analysis of the ten-microRNA signature for patients with different clinical characteristics, including age < 68 (a) or age ≥ 68 (b), stage I + II (c) or stage III + IV (d), N 0 + 1 stage (e) or N2 stage (f), M0 stage (g) or M1 stage (h), tumor free (i) or with tumor (j) and no lymphatic invasion (k) or lymphatic invasion (l)Back to article page